Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.
about
The treatment landscape in thyroid cancer: a focus on cabozantinibMultikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinibLenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancerProteomic profiling of follicular and papillary thyroid tumorsIntegrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomasEstrogens and stem cells in thyroid cancer.Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumorsIntegration of biomarkers including molecular targeted therapies in head and neck cancer.Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.Thyroid cancer: current molecular perspectives.Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.Application of molecular diagnostics to the evaluation of the surgical approach to thyroid cancerDNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells.Lessons from mouse models of thyroid cancer.Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancerClinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma.Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.Papillary thyroid carcinoma in an autonomous hyperfunctioning thyroid nodule: case report and review of the literature.MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivoDNA instability at chromosomal fragile sites in cancerEvaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinomaGenome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinomaGene expression of vitamin D metabolic enzymes at baseline and in response to vitamin D treatment in thyroid cancer cell lines.Molecular profiling of thyroid cancer subtypes using large-scale text mining.DNA topoisomerases participate in fragility of the oncogene RET.Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mousePredominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma.Differential gene expression profiling of aggressive and nonaggressive follicular carcinomasBiphasic low-grade nasopharyngeal papillary adenocarcinoma with a prominent spindle cell component: report of a case localized to the posterior nasal septum.Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.Standard and emerging therapies for metastatic differentiated thyroid cancer.The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genesThe role of fragile sites in sporadic papillary thyroid carcinomaModeling thyroid cancer in the mouse.Mouse models of thyroid cancer: A 2015 update.Comprehensive literature review: recent advances in diagnosing and managing patients with poorly differentiated thyroid carcinomaRole of DNA secondary structures in fragile site breakage along human chromosome 10B-Raf mutation and papillary thyroid carcinoma patients.
P2860
Q26796404-4455F1A8-57F4-462F-9A3B-2E73528DDDC2Q26821959-1D6A97C9-0545-4C79-8E62-294C0B17E2E2Q28072655-C4634238-BA7A-47DA-AFBC-F927D589D0CCQ28258081-43AF519E-60B0-4250-B583-F9668BB81DEBQ28475549-E37B415B-CEF2-4594-AA64-A12D527E14C0Q33358936-245A3579-73BE-4164-9E6A-9F620DF66473Q33658293-B32DB0E9-B7F2-41C2-9271-F015C3ABC4AAQ33674090-672910B1-FB64-4965-A23A-F7D0FA16CDE1Q33707821-D30A052B-D239-4452-A719-518CF6520C2AQ33760910-1CB5C0A1-6D53-4194-B91B-772F7C4F7F0FQ33782114-A6D595DF-AF7A-4AE2-A2D0-69136269BF7BQ33782121-295918D9-0E18-41A9-9CF6-2CF38410369AQ33792630-C2BCF5A5-7BBB-425D-BD6B-5B91213A069CQ33819911-223476F6-388E-4D7B-B5CB-46096C9B55ABQ33909942-7DF85CF2-CBC5-442B-BF79-5A5EEE15B96DQ33909962-EEE11B14-8BB5-4BEC-A419-6E66AFDE9F02Q33914771-C54F0FBC-9619-4C32-86F1-B47E23B9B173Q34104178-98963425-BB3E-4CDE-89DF-DF9DA98CF81DQ34109756-21180D89-4C33-4025-BB18-1677BDDA561AQ34152853-308B509D-647F-4C43-8436-6E7B64DAAC5EQ34282488-6C4A5263-3C59-47D7-B33B-B4E7C01AE7E9Q34295804-BF1F8585-FAB8-4529-B548-7A1DBB44CADDQ34572289-FDBC9876-6E1E-4540-A684-814D94B8C44CQ34701596-DB722A1C-CC1B-4C8C-AB57-57CF879F44FFQ34914970-1D7C076D-41AE-4346-8A8D-8018E7BB2360Q34990644-CC10FC9C-A2B6-46FF-8FCE-A68F0744AE6BQ35022217-0F421C7C-F21E-4322-9EAD-81892AC282FDQ35098936-9D206E91-2A20-471F-865B-23C2C2EF1F61Q35165068-83E3B517-CABC-455F-939A-232E2291357CQ35214255-1FDF53AA-7615-4528-A155-4AB8D0635BFBQ35570948-B11FAF64-D1B8-4FC7-A29B-0437D629399EQ35583906-31D81094-C3C8-4CD9-9B9D-EE784A6E727AQ35845715-3E2306A8-3AC8-4D39-B04F-63DBD4988ADEQ35906347-394810C4-6692-4F92-AAE6-6F0E2F1881F0Q36063579-10D85888-4E9F-4917-90DF-C53B0791D01EQ36297044-9368CF00-744B-421E-A4E2-B485DEC9E1BCQ36405539-4A5D44A4-FC19-4BB7-BCFA-EE6007E63CADQ36640992-D5964BD4-447C-49BB-AF85-9234D0171612Q36682494-067DF97C-9850-4939-834A-92D5A31260EEQ36741221-AF78CD43-FD07-4479-BBF8-B84BE20D99F4
P2860
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular genetics of thyroid ...... osis, treatment and prognosis.
@en
Molecular genetics of thyroid ...... osis, treatment and prognosis.
@nl
type
label
Molecular genetics of thyroid ...... osis, treatment and prognosis.
@en
Molecular genetics of thyroid ...... osis, treatment and prognosis.
@nl
prefLabel
Molecular genetics of thyroid ...... osis, treatment and prognosis.
@en
Molecular genetics of thyroid ...... osis, treatment and prognosis.
@nl
P2860
P356
P1476
Molecular genetics of thyroid ...... osis, treatment and prognosis.
@en
P2093
Marina N Nikiforova
Yuri E Nikiforov
P2860
P356
10.1586/14737159.8.1.83
P577
2008-01-01T00:00:00Z